Literature DB >> 11096003

Predictors of symptom resolution in patients with community-acquired pneumonia.

T J Marrie1, C Y Lau, S L Wheeler, C J Wong, B G Feagan.   

Abstract

Previous studies have demonstrated that a substantial number of patients with community-acquired pneumonia (CAP) experienced CAP-related symptoms up to 3 months after the completion of antibiotic treatment. We evaluated the frequency of symptoms in a cohort of 535 patients with CAP who presented to a hospital emergency department and completed symptom questionnaires 2 and 6 weeks after the completion of a course of antibiotic therapy. Six weeks after cessation of antibiotic therapy, 64% of patients still reported > or = 1 CAP-related symptoms. Exploratory analyses were performed to identify potential predictors of complete symptom resolution. Logistic regression analysis identified younger age, absence of asthma or chronic obstructive pulmonary disease, and levofloxacin treatment as predictors of complete symptom resolution (all P < .05). Randomized controlled trials should be performed to evaluate the relative efficacy of different antibiotic therapies on the rate of resolution of symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096003     DOI: 10.1086/317495

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Development and validation of a short questionnaire in community acquired pneumonia.

Authors:  R El Moussaoui; B C Opmeer; P M M Bossuyt; P Speelman; C A J M de Borgie; J M Prins
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

2.  Healthcare reconsultation in working-age adults following hospitalisation for community-acquired pneumonia.

Authors:  Priya Daniel; Thomas Bewick; Tricia M McKeever; Mark Roberts; Deborah Ashton; Daniel Smith; Lenny Latip; Wei Shen Lim
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

Review 3.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

4.  Silent Hypoxia in COVID-19: A Case Series.

Authors:  Thomas Fuehner; Isabelle Renger; Tobias Welte; Tobias Freundt; Jens Gottlieb
Journal:  Respiration       Date:  2021-11-26       Impact factor: 3.966

5.  A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days.

Authors:  Daniel G Wootton; Laura Dickinson; Henry Pertinez; Joanne Court; Odiri Eneje; Lynne Keogan; Laura Macfarlane; Sarah Wilks; Jane Gallagher; Mark Woodhead; Stephen B Gordon; Peter J Diggle
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.